News

The U.S. Food and Drug Administration (FDA) has approved, under priority review, the use of Benlysta (belimumab) for the treatment of children age 5 and older with systemic lupus erythematosus (SLE). Benlysta is a monoclonal human antibody designed to bind and block the activity of the B-lymphocyte…

When it comes to autoimmune disease, diet and lifestyle play an equal role in management and quality of life. It’s important to remember that every day is a new day, and some days will be easier and others more challenging. To navigate the ups and…

Systemic lupus erythematosus (SLE) patients are a higher risk for severe herpes simplex virus (HSV) infection, but younger age seems to be a protective factor, a study from Taiwan suggests. The research also highlights that adults (patients older than 18 ), those with a history of herpes infection, those who…

The Lupus Research Alliance (LRA) has funded a series of research projects, ongoing worldwide, aimed at seeking new therapies for people with lupus. The award recipients presented their findings at the recent 13th International Congress on Systematic Lupus Erythematosus (LUPUS 2019), in San Francisco, California. One of the…

World Lupus Day this year will focus on the need for clinical trial volunteers and how emotional support helps patients deal with the chronic autoimmune disorder. May 10 will mark the 16th annual observance of World Lupus Day, sponsored by the World Lupus Federation, an international group of more…

More and more I am humbled at the connection between the microbiome and immunity. We are continuing to learn daily how our health is connected with the relationship we have with the world around us and how we process our environment. I personally have someone in…

A group of scientists from the University of Pennsylvania may have found part of the reason lupus is more prevalent in women than in men: a defect that prevents the full inactivation of women’s second X chromosome in immune T cells. The findings of the study, “…

As part of The Patient Voice segment of the 13th International Congress on Systemic Lupus Erythematosus, prominent lupus advocate Kathleen Arntsen discussed the importance of making sure those living with the disease are heard. Known informally as Lupus 2019, the April 5-8 meeting in San Francisco, California, was…

One-quarter of systemic lupus erythematosus patients in the U.S. taking hydroxychloroquine tablets daily are exceeding the recommended doses for this treatment, and up to one-third of those on alternate-day treatment are forgetting or mixing up their medication, a study reports. The problem, researchers say, is that only 200 mg tablets…

Treatment with the investigational vaccine IFN-alpha Kinoid increased the number of systemic lupus erythematosus (SLE) patients achieving low disease activity, lessened their use of corticosteroids, and was well-tolerated, according to full results of a Phase 2b trial. The findings, “IFN Kinoid in Systemic Lupus Erythematosus (SLE):…